Provided by Macfarlanes LLP
Please visit the Macfarlanes website for more information about our work in this category: https://www.macfarlanes.com/what-we-do/services/corporate-and-ma/
Leading mid-market practice advising high-profile names on a range of transactions including acquisitions, disposals and joint ventures. Well versed in high-end work, often acting on international mandates for corporates and financial institutions. Also regularly called upon to advise management and director teams on M&A transactions. Broad international capabilities include recent experience in the USA, Europe and Australasia.
Clients affirm: "It's a very strong team which is able to give quick advice on technical points. They're knowledgeable and good to deal with."
One source reports: "They're absolutely top notch. They're really skilled, and for M&A they do a great job."
"They're excellent - very diligent, responsive and detailed," another says.
Represented Jazz Pharmaceuticals in its acquisition of GW Pharmaceuticals for USD7.2 billion.
Advised Perrigo Company on the sale of its Rosemont Pharmaceuticals business for £156 million.
Howard Corney operates a broad transactional practice encompassing expertise in public and private M&A. He advises on domestic and cross-border deals, with particular experience in those involving African interests. He serves as co-head of the corporate practice.
"He's razor-sharp with a formidable intellect, and has an aura of calm about him." "He has excellent coordination skills, a sharp eye for detail and a commercial understanding of client needs."
Charles Martin is a highly knowledgeable corporate practitioner who brings years of experience to bear in M&A deals on behalf of corporate and private equity clients. He offers board-level strategic advice in addition to his transactional counsel.